CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
3 hedge funds and large institutions have $278K invested in Global X China Biotech Innovation ETF in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$84.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.51K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$5.39K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $183K | -$5.39K | -713 | -3% |
|
|
2
Jane Street
New York
| $84.9K | +$84.9K | +11,229 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $9.51K | +$9.51K | +1,258 | New |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -100 | Closed |
|